Prothena Sees Potential In Targeting Amyloid, Validated By Biogen

CEO Gene Kinney Describes Company’s Emerging Alzheimer’s Programs

 
• By Mandy Jackson
  
Gene Kinney, CEO of Prothena
Prothena CEO Gene Kinney remains optimistic about targeting amyloid in Alzheimer's disease • Source: Prothena Corporation plc (Michelle Pattee)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category